Cargando…

Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems

Neuropsychiatric symptoms may persist following acute COVID-19 illness, but the extent to which these symptoms are specific to COVID-19 has not been established. We utilized electronic health records across 6 hospitals in Massachusetts to characterize cohorts of individuals discharged following admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Victor M., Rosand, Jonathan, Giacino, Joseph T., McCoy, Thomas H., Perlis, Roy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199464/
https://www.ncbi.nlm.nih.gov/pubmed/35705635
http://dx.doi.org/10.1038/s41380-022-01646-z
_version_ 1784727843573334016
author Castro, Victor M.
Rosand, Jonathan
Giacino, Joseph T.
McCoy, Thomas H.
Perlis, Roy H.
author_facet Castro, Victor M.
Rosand, Jonathan
Giacino, Joseph T.
McCoy, Thomas H.
Perlis, Roy H.
author_sort Castro, Victor M.
collection PubMed
description Neuropsychiatric symptoms may persist following acute COVID-19 illness, but the extent to which these symptoms are specific to COVID-19 has not been established. We utilized electronic health records across 6 hospitals in Massachusetts to characterize cohorts of individuals discharged following admission for COVID-19 between March 2020 and May 2021, and compared them to individuals hospitalized for other indications during this period. Natural language processing was applied to narrative clinical notes to identify neuropsychiatric symptom domains up to 150 days following hospitalization, in addition to those reflected in diagnostic codes as measured in prior studies. Among 6619 individuals hospitalized for COVID-19 drawn from a total of 42,961 hospital discharges, the most commonly-documented symptom domains between 31 and 90 days after initial positive test were fatigue (13.4%), mood and anxiety symptoms (11.2%), and impaired cognition (8.0%). In regression models adjusted for sociodemographic features and hospital course, none of these were significantly more common among COVID-19 patients; indeed, mood and anxiety symptoms were less frequent (adjusted OR 0.72 95% CI 0.64–0.92). Between 91 and 150 days after positivity, most commonly-detected symptoms were fatigue (10.9%), mood and anxiety symptoms (8.2%), and sleep disruption (6.8%), with impaired cognition in 5.8%. Frequency was again similar among non-COVID-19 post-hospital patients, with mood and anxiety symptoms less common (aOR 0.63, 95% CI 0.52–0.75). Propensity-score matched analyses yielded similar results. Overall, neuropsychiatric symptoms were common up to 150 days after initial hospitalization, but occurred at generally similar rates among individuals hospitalized for other indications during the same period. Post-acute sequelae of COVID-19 may benefit from standard if less-specific treatments developed for rehabilitation after hospitalization.
format Online
Article
Text
id pubmed-9199464
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91994642022-06-17 Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems Castro, Victor M. Rosand, Jonathan Giacino, Joseph T. McCoy, Thomas H. Perlis, Roy H. Mol Psychiatry Article Neuropsychiatric symptoms may persist following acute COVID-19 illness, but the extent to which these symptoms are specific to COVID-19 has not been established. We utilized electronic health records across 6 hospitals in Massachusetts to characterize cohorts of individuals discharged following admission for COVID-19 between March 2020 and May 2021, and compared them to individuals hospitalized for other indications during this period. Natural language processing was applied to narrative clinical notes to identify neuropsychiatric symptom domains up to 150 days following hospitalization, in addition to those reflected in diagnostic codes as measured in prior studies. Among 6619 individuals hospitalized for COVID-19 drawn from a total of 42,961 hospital discharges, the most commonly-documented symptom domains between 31 and 90 days after initial positive test were fatigue (13.4%), mood and anxiety symptoms (11.2%), and impaired cognition (8.0%). In regression models adjusted for sociodemographic features and hospital course, none of these were significantly more common among COVID-19 patients; indeed, mood and anxiety symptoms were less frequent (adjusted OR 0.72 95% CI 0.64–0.92). Between 91 and 150 days after positivity, most commonly-detected symptoms were fatigue (10.9%), mood and anxiety symptoms (8.2%), and sleep disruption (6.8%), with impaired cognition in 5.8%. Frequency was again similar among non-COVID-19 post-hospital patients, with mood and anxiety symptoms less common (aOR 0.63, 95% CI 0.52–0.75). Propensity-score matched analyses yielded similar results. Overall, neuropsychiatric symptoms were common up to 150 days after initial hospitalization, but occurred at generally similar rates among individuals hospitalized for other indications during the same period. Post-acute sequelae of COVID-19 may benefit from standard if less-specific treatments developed for rehabilitation after hospitalization. Nature Publishing Group UK 2022-06-15 2022 /pmc/articles/PMC9199464/ /pubmed/35705635 http://dx.doi.org/10.1038/s41380-022-01646-z Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Castro, Victor M.
Rosand, Jonathan
Giacino, Joseph T.
McCoy, Thomas H.
Perlis, Roy H.
Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems
title Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems
title_full Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems
title_fullStr Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems
title_full_unstemmed Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems
title_short Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems
title_sort case-control study of neuropsychiatric symptoms in electronic health records following covid-19 hospitalization in 2 academic health systems
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199464/
https://www.ncbi.nlm.nih.gov/pubmed/35705635
http://dx.doi.org/10.1038/s41380-022-01646-z
work_keys_str_mv AT castrovictorm casecontrolstudyofneuropsychiatricsymptomsinelectronichealthrecordsfollowingcovid19hospitalizationin2academichealthsystems
AT rosandjonathan casecontrolstudyofneuropsychiatricsymptomsinelectronichealthrecordsfollowingcovid19hospitalizationin2academichealthsystems
AT giacinojosepht casecontrolstudyofneuropsychiatricsymptomsinelectronichealthrecordsfollowingcovid19hospitalizationin2academichealthsystems
AT mccoythomash casecontrolstudyofneuropsychiatricsymptomsinelectronichealthrecordsfollowingcovid19hospitalizationin2academichealthsystems
AT perlisroyh casecontrolstudyofneuropsychiatricsymptomsinelectronichealthrecordsfollowingcovid19hospitalizationin2academichealthsystems